Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ABTX - Agribiotech -- Ignore unavailable to you. Want to Upgrade?

To: KurtVedder who wrote (7346)	2/1/1999 2:27:00 AM
From: StilKrazy	Respond to of 8359

My favorite part: "The Company will continue to have discussions concerning equity infusions with potential equity partners, while also discussing other business arrangements. The Company does not anticipate making additional comments on this matter until finite conclusions are achieved, whether successful or unsuccessful." Thank god. This is, I believe, the next best thing to not having shut up in the first place. It's factual, sets no deadlines, and leaves room for optimism (IMO). Whatever else they've said before, they're saying that they continue to pursue a variety of alternatives aimed at increasing value. I don't know how to read this any other way, and I've obviously no way to verify it's accuracy. I therefore choose to accept it as the truth, and will act accordingly. "In addition, during the past two months, the Company had made several announcements concerning the private placement of equity and convertible debt and the sale of certain non-seed assets of Willamette Seed Co. The transactions have permitted the Company to pay off the $15 million overadvance facility under its Revolving Credit Facility with Bank America Business Credit and the $15 million bridge loan from Deutsche Bank AG." In the midst of potentially sensitive negotiations, I doubt that it would be prudent to say more about this and their overall indebtedness. The problem with confidentiality agreements is that any one, even a reporter on a crusade, can pretty much say whatever s/he wants to say, publish and interpret provocative issues in a slanted fashion, and generally help deteriorate shareholders' confidence by taking advantage of the company's agreed-upon stance to remain silent during negotiations. ABT has no real opportunity to respond in a comprehensive way without also jeopardizing their position within the negotiations. In effect, the propaganda that's planted creates a readiness, a predisposition, among those of us who've already been hurt to be skeptical about any "news" from the company, particularly in the wake of such traumatic experiences of abandonment and betrayal. On another level, disinformation also creates a sense of gratitude and relief were the stock to reach a respectable price range, say $10 - $14, rendering the stock once again a terrific short play with so many people happy to simply get out without having their asses handed to them. POWs in Korea and Vietnam were so grateful and relieved that their captors hadn't killed them while torturing them, that they developed strong bonds with them that were not easy to modify or break. Bloomberg and their supporters, I believe, have greatly contributed to an environment in which the goal for many is no longer to see their investment grow alongside ABT, but to simply get out alive. The only reason people do such things is because they often work.